Managing Avelumab Side Effects in Patients With Merkel Cell Carcinoma
2 Lượt xem
administrator
07/17/23
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses the adverse event profile of avelumab (Bavencio) for patients with Merkel cell carcinoma.
Cho xem nhiều hơn
Bình luận trên Facebook
Không có bình luận nào được tìm thấy